Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.
Beskrivning
Contains 12 relevant, practice-oriented topics including theragnostics trials; neuroendocrine tumors: diagnostics; prostate-specific membrane antigen: diagnostics; theragnostics: post-therapy imaging; fibroblast-activation-protein inhibitors (FAPI) theragnostics; and more.
Provides in-depth clinical reviews on theragnostics, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Alpha and Beta Radiation for TheragnosticsNeuroendocrine Tumors: DiagnosticsAlpha-emitter Peptide Receptor Radionuclide Therapy in Neuroendocrine TumorsProstate-specific Membrane Antigen: DiagnosticsProstate-specific Membrane Antigen: Interpretation Criteria, Standardized Reporting, and the Use of Machine LearningProstate-specific Membrane Antigen: Alpha-labeled RadiopharmaceuticalsProstate Cancer Radioligand Therapy: Beta-labeled RadiopharmaceuticalsGastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management: Preclinical and Clinical Developments of the Past 5 YearsTreatment Response Imaging in Prostate CancerHepatic Radioembolization: A Multistep Theragnostic Procedure
